These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27163476)

  • 1. Letter to the Editor: Strontium Ranelate in the Treatment of Osteoporosis: A Possible Mechanism.
    Sugiyama T; Kim YT; Oda H
    J Clin Endocrinol Metab; 2016 May; 101(5):L64-5. PubMed ID: 27163476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strontium ranelate (Osseor)--unique double mechanism--physiologic bone treatment as live tissue].
    Novak S
    Reumatizam; 2007; 54(2):83-4. PubMed ID: 18351151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis].
    Callejas Rubio JL; López Pérez L; Sánchez Cano D; Ortego Centeno N
    Med Clin (Barc); 2006 Jul; 127(7):279. PubMed ID: 16942738
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium ranelate for osteoporosis?
    Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate--a promising therapeutic principle in osteoporosis.
    Boivin G; Doublier A; Farlay D
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):153-6. PubMed ID: 22565017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
    Novak S
    Reumatizam; 2008; 55(2):75-7. PubMed ID: 19024282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strontium ranelate--new paradigm in the treatment of postmenopausal osteoporosis].
    Korsić M; Giljević Z; Kastelan D
    Lijec Vjesn; 2006; 128(5-6):180-2. PubMed ID: 16910420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate: new perspectives for the management of osteoporosis.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv1-2. PubMed ID: 19783588
    [No Abstract]   [Full Text] [Related]  

  • 12. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 13. Strontium ranelate: a look back at its use for osteoporosis.
    Reginster JY; Neuprez A
    Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY; Malaise O; Neuprez A; Bruyere O
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate: a novel mode of action leading to renewed bone quality.
    Ammann P
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S11-5. PubMed ID: 15578157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
    Boonen S
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.